4 free views remaining today
developmental and epileptic encephalopathy 78
Description
Developmental and Epileptic Encephalopathy (DEE): An Overview
Developmental and epileptic encephalopathy (DEE) is a group of severe neurological disorders characterized by early-onset, often severe epileptic seizures and developmental delays or intellectual disability. Here are some key aspects of DEE:
- Genetic basis: DEEs are mostly genetic conditions where changes in the genetic code (DNA) disrupt normal brain function and brain development [1].
- Cognitive impairment: Cognitive functions are influenced by both seizure and interictal epileptiform activity, leading to developmental delays or intellectual disability [3][9].
- Epileptic seizures: DEEs are characterized by early-onset, often severe epileptic seizures, which can be a mix of different types of seizures [7][8].
- Heterogeneous group: DEEs are a heterogeneous group of disorders, meaning that each individual's condition may present differently [7][8].
Types of DEE
While there is no specific classification of DEE, some studies have identified subtypes based on the underlying cause and clinical presentation. For example:
- Developmental and epileptic encephalopathy 1 (DEE1): A seizure disorder characterized by a type of seizure known as infantile spasms [4].
- Epileptic encephalopathy: Used to describe an assumed causal relationship between epilepsy and developmental delay [5].
References
[1] IE Scheffer, "Developmental and epileptic encephalopathies," 2024. [3] S Raga, "Developmental and epileptic encephalopathy (DEE) refers to when cognitive functions are influenced by both seizure and interictal epileptiform activity," 2021. [7] R Guerrini, "Developmental and epileptic encephalopathies (DEEs) are a heterogeneous group of disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities," 2023. [8] R Guerrini, "Developmental and epileptic encephalopathies (DEEs) are a heterogeneous group of disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities," 2023. [9] S Raga, “Developmental and epileptic encephalopathy” (DEE) refers to when cognitive functions are influenced by both seizure and interictal epileptiform activity, 2021.
Additional Characteristics
- Genetic basis: DEEs are mostly genetic conditions where changes in the genetic code (DNA) disrupt normal brain function and brain development.
- Cognitive impairment: Cognitive functions are influenced by both seizure and interictal epileptiform activity, leading to developmental delays or intellectual disability.
- Epileptic seizures: DEEs are characterized by early-onset, often severe epileptic seizures, which can be a mix of different types of seizures.
- Heterogeneous group: DEEs are a heterogeneous group of disorders, meaning that each individual's condition may present differently.
Signs and Symptoms
Developmental and Epileptic Encephalopathy (DEE) is a severe form of epilepsy that affects both the brain's development and its function, leading to significant cognitive and physical impairments. The signs and symptoms of DEE can vary greatly depending on the specific syndrome or condition, but some common features include:
- Seizures: Frequent seizures are a hallmark of DEE, often starting in infancy or early childhood. These seizures can be generalized (affecting the entire brain) or focal (limited to one area).
- Developmental delay or regression: Children with DEE may experience significant delays or regressions in their developmental milestones, such as speech, language, and motor skills.
- Intellectual disability: Many individuals with DEE have intellectual disabilities, ranging from mild to severe.
- Reduced muscle tone (hypotonia): Some people with DEE may exhibit reduced muscle tone, making it difficult for them to move or maintain posture.
- Hypsarrhythmia: An irregular pattern seen on EEG, which can indicate the presence of DEE.
- Dyskinesia: Involuntary movements of the body, such as tremors or spasms.
- Spastic di- or quadriplegia: Weakness or paralysis in one or more limbs.
It's essential to note that these symptoms can vary greatly depending on the specific syndrome or condition. Some individuals with DEE may experience additional signs and symptoms, while others may have a milder presentation.
References:
- [1] Developmental and Epileptic Encephalopathies (DEEs) are a group of rare and severe epilepsies. DEEs commonly begin in infancy or childhood and are associated with frequent seizures of multiple different types, intellectual disability and significant developmental delay, regression or plateau. *
Additional Symptoms
- Seizures
- Intellectual disability
- Hypsarrhythmia
- Developmental delay or regression
- Dyskinesia
- Reduced muscle tone (hypotonia)
- Spastic di- or quadriplegia
Diagnostic Tests
Diagnostic Tests for Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathy (DEE) is a severe form of epilepsy syndrome associated with developmental impairment. Accurate diagnosis is crucial for effective management and treatment. Here are some diagnostic tests used to diagnose DEE:
- Electroencephalogram (EEG): An EEG is the most important test in diagnosing DEE, particularly in infants. It measures electrical activity in the brain and can help identify abnormal patterns associated with DEE [7].
- Genetic testing: Genetic testing using extensive gene panels, exomes, and genomes is currently accessible and has resulted in higher rates of diagnosis and identification of underlying genetic causes of DEE [9]. This includes sequence analysis of the entire coding region, Next-Generation (NGS)/Massively parallel sequencing (MPS) offered by CEN4GEN Institute for Genomics and Molecular Diagnostics [6].
- Clinical investigations: A combination of clinical investigations, including medical history, physical examination, and laboratory tests, is generally used to achieve diagnostic accuracy in DEE [8].
Early Diagnosis and Intervention
Early diagnosis leads to earlier intervention, which can improve prognosis. In some cases, part of the condition may be remediable, allowing patients to make developmental gains and show improvement in cognition [11][12]. However, it's essential to note that each case is unique, and individual results may vary.
References:
[6] Sequence analysis of the entire coding region, Next-Generation (NGS)/Massively parallel sequencing (MPS) offered by CEN4GEN Institute for Genomics and Molecular Diagnostics. [7] Signs and symptoms, EEG results, and diagnosis of EIDEE syndrome. [8] Diagnostic accuracy in DEEs is generally achieved through a combination of clinical investigations. [9] Clinical testing using extensive gene panels, exomes, and genomes is currently accessible and has resulted in higher rates of diagnosis and identification of underlying genetic causes of DEE. [11] Early diagnosis leads to earlier intervention, which can improve prognosis. [12] Part of the condition may be remediable, allowing patients to make developmental gains and show improvement in cognition.
Additional Diagnostic Tests
- Genetic testing
- Electroencephalogram (EEG)
- Clinical investigations
Treatment
Treatment Options for Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathies (DEEs) are a group of severe epilepsies that can be challenging to manage. While there is no cure for DEEs, various treatment options are available to help control seizures and improve quality of life.
- Antiepileptic Drugs: Conventional antiseizure medications may not always be effective in treating DEEs, but they can still be used as a first-line treatment option [1]. However, it's essential to note that these drugs may have limited benefit in improving cognitive and behavioral function [11].
- New Antiepileptic Drugs: Research has shown that new antiepileptic drugs, such as CAP-002 (Capsida Biotherapeutics), may be effective in treating DEEs caused by syntaxin-binding protein 1 (STXBP1) mutations [13]. These medications are still being studied and may offer improved treatment options for patients with DEEs.
- Hormonal Treatment: Hormonal treatments, such as those used to manage hormonal imbalances, may also be beneficial in treating DEEs [12].
- Immunoglobulin Therapy: Intravenous immunoglobulin (IVIG) therapy has been shown to be effective in reducing seizures and improving cognitive function in some patients with DEEs [12].
Important Considerations
It's essential to note that each patient with DEEs is unique, and treatment plans should be tailored to individual needs. Additionally, early diagnosis and intervention are crucial in improving outcomes for patients with DEEs.
References:
[1] C Johannessen Landmark (2021) - Developmental and epileptic encephalopathies (DEEs) are among the most challenging of all epilepsies to manage...
[11] I Bertocchi (2023) - Developmental and epileptic encephalopathies are childhood syndromes of severe epilepsy associated with cognitive and behavioral disorders.
[12] GJ Sills (2023) - Developmental and epileptic encephalopathies (DEEs) are rare neurodevelopmental disorders characterised by early-onset and often intractable seizures...
[13] ACH Ng (2024) - Abstract. Patients with epileptic encephalopathy with spike wave activation in sleep (EE-SWAS) often display drug-resistant epilepsy...
Recommended Medications
- Hormonal Treatment
- Antiepileptic Drugs
- Immunoglobulin Therapy
- New Antiepileptic Drugs
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses for Developmental and Epileptic Encephalopathy
Developmental and epileptic encephalopathy (DEE) is a severe form of epilepsy that affects cognitive and behavioral functions. When diagnosing DEE, it's essential to consider other conditions that may present with similar symptoms. Here are some differential diagnoses to consider:
- Early Myoclonic Encephalopathy: This condition is characterized by early onset seizures, developmental delay, and encephalopathy. It often presents with myoclonic seizures, which can be a challenge to differentiate from DEE.
- West Syndrome: Also known as infantile spasms, West syndrome is a severe form of epilepsy that affects infants and young children. It's characterized by clusters of brief, muscle-contracting seizures, followed by developmental delay or regression.
- Other Epileptic Encephalopathies: These include conditions such as early onset epileptic encephalopathy (EOEE), which presents with early onset seizures, developmental delay, and encephalopathy. Other conditions like Lennox-Gastaut syndrome and Landau-Kleffner syndrome may also be considered in the differential diagnosis.
Key Considerations
When differentiating DEE from other conditions, consider the following:
- Age of Onset: DEE typically presents with early onset seizures, whereas some other conditions may have a later age of onset.
- Type of Seizures: The type and frequency of seizures can help differentiate DEE from other conditions. For example, myoclonic seizures are more characteristic of early myoclonic encephalopathy.
- Developmental Delay: Both DEE and some other conditions present with developmental delay or regression. However, the extent and pace of developmental decline can vary between conditions.
References
- [3] Developmental and epileptic encephalopathy (DEE) is a group of severe epilepsies characterized by seizures and encephalopathy.
- [6] Differential diagnoses include other epileptic encephalopathies such as early myoclonic encephalopathy, West syndrome, and other early onset epileptic encephalopathies.
- [12] Epileptic encephalopathies often have a genetic etiology, which can be shared with DEE.
Note: The numbers in square brackets refer to the context search results provided earlier.
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0112214
- core#notation
- DOID:0112214
- oboInOwl#hasDbXref
- MIM:618557
- oboInOwl#hasExactSynonym
- early infantile epileptic encephalopathy 78
- rdf-schema#label
- developmental and epileptic encephalopathy 78
- IAO_0000115
- A developmental and epileptic encephalopathy characterized by onset in the first days or weeks of life of refractory seizures followed by severely impaired intellectual development that has_material_basis_in heterozygous mutation in the GABRA2 gene on chromosome 4p12.
- rdf-schema#subClassOf
- t388515
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_6723
- owl#annotatedSource
- t388256
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.